Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Accounts Payables (2016 - 2021)

Historic Accounts Payables for ENDRA Life Sciences (NDRA) over the last 6 years, with Q3 2021 value amounting to $1.4 million.

  • ENDRA Life Sciences' Accounts Payables rose 936.79% to $1.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.4 million, marking a year-over-year increase of 936.79%. This contributed to the annual value of $910183.0 for FY2020, which is 4672.7% down from last year.
  • Latest data reveals that ENDRA Life Sciences reported Accounts Payables of $1.4 million as of Q3 2021, which was up 936.79% from $1.5 million recorded in Q2 2021.
  • In the past 5 years, ENDRA Life Sciences' Accounts Payables ranged from a high of $1.7 million in Q4 2019 and a low of $162302.0 during Q2 2017
  • Moreover, its 5-year median value for Accounts Payables was $974583.0 (2018), whereas its average is $1.0 million.
  • Its Accounts Payables has fluctuated over the past 5 years, first surged by 36294.93% in 2018, then crashed by 5244.92% in 2021.
  • Over the past 5 years, ENDRA Life Sciences' Accounts Payables (Quarter) stood at $848214.0 in 2017, then rose by 14.9% to $974583.0 in 2018, then soared by 75.31% to $1.7 million in 2019, then plummeted by 46.73% to $910183.0 in 2020, then skyrocketed by 59.21% to $1.4 million in 2021.
  • Its Accounts Payables stands at $1.4 million for Q3 2021, versus $1.5 million for Q2 2021 and $686650.0 for Q1 2021.